Investing In Janux Therapeutics Inc (NASDAQ: JANX): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Janux Therapeutics Inc is $3.66B. A total of 0.91 million shares were traded on the day, compared to an average of 943.28K shares.

In the most recent transaction, Campbell David Alan sold 15,000 shares of JANX for 67.00 per share on Dec 03 ’24. After the transaction, the President and CEO now owns 242,054 company shares. In a previous transaction on Nov 25 ’24, Campbell David Alan sold 25,000 shares at 51.60 per share. JANX shares that President and CEO owns now total 257,054.

Among the insiders who bought shares, Reardon Tighe acquired of 5,202 shares on Nov 01 ’24 at a per-share price of $53.44. In another insider transaction, Lichter Jay bought 1,139 shares at $53.31 per share on Nov 01 ’24.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, JANX has a high of $71.71 and a low of $7.79.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. JANX’s latest balance sheet shows that the firm has $374.96M in Cash & Short Term Investments as of fiscal 2021. There were $194.00k in debt and $12.80M in liabilities at the time. Its Book Value Per Share was $12.54, while its Total Shareholder’s Equity was $366.33M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JANX is Buy with a score of 4.82.

Most Popular

Related Posts